Clinical Trial Update: Vaccination With Autologous Dendritic Cells Pulsed With HIV-Antigens for Treatment of Patients With Chronic HIV-Infection [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating an autologous dendritic cell vaccine pulsed with HIV antigens for chronic HIV infection. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Autologous dendritic cell vaccine pulsed with HIV antigens

Snippet

Sponsor: Statens Serum Institut | Conditions: HIV Infections | Phase 1 | Status: COMPLETED